Reyvow

Product NDC: 0002-4736
Requested package NDC: 0002-4736-08
11-digit product format: 000024736
Labeler code: 0002
Product ID: 0002-4736_f22c3672-c15f-4235-964a-3bda17de53f7
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: lasmiditan
Dosage form: TABLET
Route: ORAL
Labeler: Eli Lilly and Company
Application: NDA211280
Marketing category: NDA
Marketing start: 2020-12-18
Marketing end: 0000-00-00
Substance: LASMIDITAN
Active strength: 200 mg/1
DEA schedule: CV
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	0002-4736	0002-4736-08	D	Discontinued by firm		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N211280-001	REYVOW	LASMIDITAN SUCCINATE	EQ 50MG BASE	TABLET / ORAL	RLD	2020-01-31
N211280-002	REYVOW	LASMIDITAN SUCCINATE	EQ 100MG BASE	TABLET / ORAL	RLD	2020-01-31
N211280-003	REYVOW	LASMIDITAN SUCCINATE	EQ 200MG BASE	TABLET / ORAL	RLD	2020-12-18

Orange Book patents#

Current patent rows page 1 of 1 · 11 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N211280-001	7423050	2028-02-17	U-1719	Drug substance, Drug product	2020-02-25
N211280-001	12257246	2030-07-07	U-2718		2025-04-22
N211280-001	11053214	2037-12-05	U-1719	Drug substance, Drug product	2021-07-28
N211280-001	12071423	2040-07-06		Drug product	2024-09-20
N211280-002	7423050	2028-02-17	U-1719	Drug substance, Drug product	2020-02-25
N211280-002	12257246	2030-07-07	U-2718		2025-04-22
N211280-002	11053214	2037-12-05	U-1719	Drug substance, Drug product	2021-07-28
N211280-002	12071423	2040-07-06		Drug product	2024-09-20
N211280-003	7423050	2028-02-17	U-1719	Drug substance, Drug product	2021-07-28
N211280-003	12257246	2030-07-07	U-2718		2025-04-22
N211280-003	11053214	2037-12-05	U-1719	Drug substance, Drug product	2021-07-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 115 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N211280-001	REYVOW	EQ 50MG BASE	TABLET / ORAL	RLD	2020-01-31	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N211280-002	REYVOW	EQ 100MG BASE	TABLET / ORAL	RLD	2020-01-31	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N211280-003	REYVOW	EQ 200MG BASE	TABLET / ORAL	RLD	2020-12-18	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N211280-001	REYVOW	EQ 50MG BASE	TABLET / ORAL	RLD	2020-01-31	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N211280-002	REYVOW	EQ 100MG BASE	TABLET / ORAL	RLD	2020-01-31	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N211280-003	REYVOW	EQ 200MG BASE	TABLET / ORAL	RLD	2020-12-18	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N211280-001	REYVOW	EQ 50MG BASE	TABLET / ORAL	RLD	2020-01-31	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N211280-002	REYVOW	EQ 100MG BASE	TABLET / ORAL	RLD, RS	2020-01-31	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N211280-003	REYVOW	EQ 200MG BASE	TABLET / ORAL	RLD	2020-12-18	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N211280-001	REYVOW	EQ 50MG BASE	TABLET / ORAL	RLD	2020-01-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N211280-002	REYVOW	EQ 100MG BASE	TABLET / ORAL	RLD, RS	2020-01-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N211280-003	REYVOW	EQ 200MG BASE	TABLET / ORAL	RLD	2020-12-18	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N211280-001	REYVOW	EQ 50MG BASE	TABLET / ORAL	RLD	2020-01-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N211280-002	REYVOW	EQ 100MG BASE	TABLET / ORAL	RLD, RS	2020-01-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N211280-003	REYVOW	EQ 200MG BASE	TABLET / ORAL	RLD	2020-12-18	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N211280-001	REYVOW	EQ 50MG BASE	TABLET / ORAL	RLD	2020-01-31	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N211280-002	REYVOW	EQ 100MG BASE	TABLET / ORAL	RLD, RS	2020-01-31	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N211280-003	REYVOW	EQ 200MG BASE	TABLET / ORAL	RLD	2020-12-18	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N211280-001	REYVOW	EQ 50MG BASE	TABLET / ORAL	RLD	2020-01-31	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N211280-002	REYVOW	EQ 100MG BASE	TABLET / ORAL	RLD, RS	2020-01-31	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N211280-003	REYVOW	EQ 200MG BASE	TABLET / ORAL	RLD	2020-12-18	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N211280-001	REYVOW	EQ 50MG BASE	TABLET / ORAL	RLD	2020-01-31	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N211280-002	REYVOW	EQ 100MG BASE	TABLET / ORAL	RLD, RS	2020-01-31	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N211280-003	REYVOW	EQ 200MG BASE	TABLET / ORAL	RLD	2020-12-18	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N211280-001	REYVOW	EQ 50MG BASE	TABLET / ORAL	RLD	2020-01-31	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N211280-002	REYVOW	EQ 100MG BASE	TABLET / ORAL	RLD, RS	2020-01-31	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N211280-003	REYVOW	EQ 200MG BASE	TABLET / ORAL	RLD	2020-12-18	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N211280-001	REYVOW	EQ 50MG BASE	TABLET / ORAL	RLD	2020-01-31	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N211280-002	REYVOW	EQ 100MG BASE	TABLET / ORAL	RLD, RS	2020-01-31	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N211280-003	REYVOW	EQ 200MG BASE	TABLET / ORAL	RLD	2020-12-18	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N211280-001	REYVOW	EQ 50MG BASE	TABLET / ORAL	RLD	2020-01-31	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N211280-002	REYVOW	EQ 100MG BASE	TABLET / ORAL	RLD, RS	2020-01-31	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N211280-003	REYVOW	EQ 200MG BASE	TABLET / ORAL	RLD	2020-12-18	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N211280-001	REYVOW	EQ 50MG BASE	TABLET / ORAL	RLD	2020-01-31	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N211280-002	REYVOW	EQ 100MG BASE	TABLET / ORAL	RLD, RS	2020-01-31	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N211280-003	REYVOW	EQ 200MG BASE	TABLET / ORAL	RLD	2020-12-18	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N211280-001	REYVOW	EQ 50MG BASE	TABLET / ORAL	RLD	2020-01-31	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N211280-002	REYVOW	EQ 100MG BASE	TABLET / ORAL	RLD, RS	2020-01-31	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N211280-003	REYVOW	EQ 200MG BASE	TABLET / ORAL	RLD	2020-12-18	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N211280-001	REYVOW	EQ 50MG BASE	TABLET / ORAL	RLD	2020-01-31	`301d65b070ca…`

Observed Orange Book patent history#

Patent history page 1 of 8 · 316 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N211280-001	7423050	2028-02-17	U-1719	Drug substance, Drug product	2020-02-25	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N211280-001	12257246	2030-07-07	U-2718		2025-04-22	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N211280-001	11053214	2037-12-05	U-1719	Drug substance, Drug product	2021-07-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N211280-001	12071423	2040-07-06		Drug product	2024-09-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N211280-002	7423050	2028-02-17	U-1719	Drug substance, Drug product	2020-02-25	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N211280-002	12257246	2030-07-07	U-2718		2025-04-22	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N211280-002	11053214	2037-12-05	U-1719	Drug substance, Drug product	2021-07-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N211280-002	12071423	2040-07-06		Drug product	2024-09-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N211280-003	7423050	2028-02-17	U-1719	Drug substance, Drug product	2021-07-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N211280-003	12257246	2030-07-07	U-2718		2025-04-22	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N211280-003	11053214	2037-12-05	U-1719	Drug substance, Drug product	2021-07-28	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N211280-001	7423050	2028-02-17	U-1719	Drug substance, Drug product	2020-02-25	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N211280-001	12257246	2030-07-07	U-2718		2025-04-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N211280-001	11053214	2037-12-05	U-1719	Drug substance, Drug product	2021-07-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N211280-001	12071423	2040-07-06		Drug product	2024-09-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N211280-002	7423050	2028-02-17	U-1719	Drug substance, Drug product	2020-02-25	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N211280-002	12257246	2030-07-07	U-2718		2025-04-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N211280-002	11053214	2037-12-05	U-1719	Drug substance, Drug product	2021-07-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N211280-002	12071423	2040-07-06		Drug product	2024-09-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N211280-003	7423050	2028-02-17	U-1719	Drug substance, Drug product	2021-07-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N211280-003	12257246	2030-07-07	U-2718		2025-04-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N211280-003	11053214	2037-12-05	U-1719	Drug substance, Drug product	2021-07-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N211280-001	7423050	2028-02-17	U-1719	Drug substance, Drug product	2020-02-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N211280-001	12257246	2030-07-07	U-2718		2025-04-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N211280-001	11053214	2037-12-05	U-1719	Drug substance, Drug product	2021-07-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N211280-001	12071423	2040-07-06		Drug product	2024-09-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N211280-002	7423050	2028-02-17	U-1719	Drug substance, Drug product	2020-02-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N211280-002	12257246	2030-07-07	U-2718		2025-04-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N211280-002	11053214	2037-12-05	U-1719	Drug substance, Drug product	2021-07-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N211280-002	12071423	2040-07-06		Drug product	2024-09-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N211280-003	7423050	2028-02-17	U-1719	Drug substance, Drug product	2021-07-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N211280-003	12257246	2030-07-07	U-2718		2025-04-22	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N211280-003	11053214	2037-12-05	U-1719	Drug substance, Drug product	2021-07-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N211280-001	7423050	2028-02-17	U-1719	Drug substance, Drug product	2020-02-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N211280-001	12257246	2030-07-07	U-2718		2025-04-22	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N211280-001	11053214	2037-12-05	U-1719	Drug substance, Drug product	2021-07-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N211280-001	12071423	2040-07-06		Drug product	2024-09-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N211280-002	7423050	2028-02-17	U-1719	Drug substance, Drug product	2020-02-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N211280-002	12257246	2030-07-07	U-2718		2025-04-22	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N211280-002	11053214	2037-12-05	U-1719	Drug substance, Drug product	2021-07-28	`31067a03dcf5…`

Observed Orange Book exclusivity history#

Exclusivity history page 1 of 3 · 101 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N211280-001	NCE	2025-01-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N211280-002	NCE	2025-01-31	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N211280-003	NCE	2025-01-31	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N211280-001	NCE	2025-01-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N211280-002	NCE	2025-01-31	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N211280-003	NCE	2025-01-31	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N211280-001	NCE	2025-01-31	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N211280-002	NCE	2025-01-31	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N211280-003	NCE	2025-01-31	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N211280-001	NCE	2025-01-31	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N211280-002	NCE	2025-01-31	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N211280-003	NCE	2025-01-31	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N211280-001	NCE	2025-01-31	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N211280-002	NCE	2025-01-31	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N211280-003	NCE	2025-01-31	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N211280-001	NCE	2025-01-31	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N211280-002	NCE	2025-01-31	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N211280-003	NCE	2025-01-31	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N211280-001	NCE	2025-01-31	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N211280-002	NCE	2025-01-31	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N211280-003	NCE	2025-01-31	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N211280-001	NCE	2025-01-31	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N211280-002	NCE	2025-01-31	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N211280-003	NCE	2025-01-31	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N211280-001	NCE	2025-01-31	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N211280-002	NCE	2025-01-31	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N211280-003	NCE	2025-01-31	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N211280-001	NCE	2025-01-31	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N211280-002	NCE	2025-01-31	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N211280-003	NCE	2025-01-31	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N211280-001	NCE	2025-01-31	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N211280-002	NCE	2025-01-31	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N211280-003	NCE	2025-01-31	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N211280-001	NCE	2025-01-31	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N211280-002	NCE	2025-01-31	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N211280-003	NCE	2025-01-31	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N211280-001	NCE	2025-01-31	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N211280-002	NCE	2025-01-31	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N211280-003	NCE	2025-01-31	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N211280-001	NCE	2025-01-31	`5c6f7cd8ea54…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Reyvow	LASMIDITAN	Eli Lilly and Company	aea3358c-ff41-4490-9e6d-c7bf7b3de13f	2026-01-08	Warnings, Adverse reactions	Exact identifier application applno (NDA): 211280 application number: NDA211280

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
760I9WM792	LASMIDITAN	439239-90-4	LASMIDITAN

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0002-4736-08	00002473608	2 BLISTER PACK in 1 CARTON (0002-4736-08) > 4 TABLET in 1 BLISTER PACK	2 blister pack	2020-12-18	0000-00-00	No	No	Current